How to Value a Company With No Profits

Introduction

Some of the most valuable companies in the world lose money. AI labs valued in the hundreds of billions, fast-growing software businesses, biotech firms with no approved products, and pre-IPO disruptors all share a problem that breaks the standard valuation toolkit: they have no profits to value. If you try to apply a price-to-earnings ratio to a company with negative earnings, you get a meaningless negative number. If you reach for EV/EBITDA, you find EBITDA is negative too. So how does the market arrive at a $50 billion valuation for a business that has never made a dime?

The answer is that you stop valuing what the company earns today and start valuing what it credibly can earn tomorrow. That means anchoring on the top line rather than the bottom line, judging the trajectory of growth, and stress-testing whether the underlying unit economics can ever turn a profit at scale. This is the central valuation challenge of the AI and software era, and it is a favorite interview topic precisely because it forces you to reason from first principles rather than plug numbers into a formula. This post walks through the full toolkit: revenue multiples, the Rule of 40, unit economics, the path to profitability, and where the AI boom fits in.

The valuation methods most candidates learn first all assume the company makes money. Strip the profit away and they stop working, which is why you need a different lens for high-growth, loss-making businesses.

The price-to-earnings problem

The price-to-earnings ratio divides share price by earnings per share. When earnings are negative, the ratio is negative and tells you nothing useful, which is why data providers simply mark it "NM" for not meaningful. A company losing money has no E for the P to sit on top of, so the entire framework collapses.

The EV/EBITDA problem

EV/EBITDA is more robust because it strips out capital structure and non-cash charges, but it fails for the same root reason: a company burning cash to fund growth usually has negative EBITDA. You cannot pay a sensible multiple of a negative number. This is exactly why the common valuation multiples you would use for a mature business need to be swapped out for top-line measures here.

What you value instead

With the bottom line unusable, valuation shifts up the income statement to revenue, the one number that is reliably positive and growing. The logic is that revenue today is a proxy for profits later, provided the business can eventually convert sales into earnings. The whole exercise becomes a structured bet on that conversion, which is why the rest of this article is really about judging how believable the path to profit is.

Revenue Multiple

A valuation metric that divides a company's enterprise value by its revenue (EV/Revenue), used when earnings are negative or too small to be meaningful. It values a business on its top line rather than its profits, on the assumption that revenue will convert into earnings as the company matures.

The workhorse metric for an unprofitable company is the revenue multiple, usually expressed as enterprise value divided by revenue.

EV/Revenue and why enterprise value matters

You use enterprise value, not equity value or market cap, because revenue belongs to the whole capital structure, not just shareholders. Getting that bridge right is essential, and our guide on enterprise value versus equity value explains why. A company trading at 8x revenue with $200 million of sales carries an enterprise value of $1.6 billion, and the entire debate becomes whether 8x is too high, too low, or about right given growth and margins.

ARR multiples for subscription businesses

For subscription software, analysts often use annual recurring revenue (ARR) instead of reported revenue, because ARR captures the run-rate value of contracted, repeating revenue rather than a backward-looking annual figure. A SaaS company exiting the year at $240 million of ARR is valued on that forward run rate, which better reflects the recurring, high-retention nature of the model.

Annual Recurring Revenue (ARR)

The annualized value of a company's recurring subscription revenue, calculated from its current run rate rather than trailing reported revenue. ARR is the preferred top-line metric for subscription software because it captures contracted, repeating revenue and smooths out one-time items.

Forward multiples: NTM versus LTM

A crucial refinement is whether the multiple is built on the last twelve months (LTM) or the next twelve months (NTM) of revenue. For a company growing 50% a year, the difference is enormous: an NTM multiple looks far lower than an LTM multiple on the same price, because the denominator is much bigger. High-growth companies are almost always quoted on forward revenue, since the market is paying for tomorrow's scale, not yesterday's.

Sharpen your valuation toolkit: Practice over 1,000 technical questions covering multiples, DCF, and growth-company valuation, download our iOS app to prepare for every angle.

Because a revenue multiple means nothing without context, the market needed a single yardstick that blends growth and profitability. That yardstick is the Rule of 40.

How the rule works

The idea is that a software company's revenue growth rate plus its profit margin should exceed 40%. A business growing 60% while losing 20% of revenue still scores 40 and is considered healthy, because its growth more than justifies its burn. A business growing only 15% while breaking even scores just 15 and looks weak. The rule elegantly captures the core trade-off of an unprofitable growth company: losses are acceptable if, and only if, growth is fast enough to pay for them.

Why it maps to valuation

Empirically, higher Rule of 40 scores correlate with higher revenue multiples. Companies scoring 60 and above earn premium multiples, while those below 30 see their multiples compressed. The market is effectively using the score as a shortcut for the quality of growth. This matters today because the bar is high: as of late 2025, the median public SaaS company scored only about 28%, and only roughly one in five exceeded 40, a sign of how much the growth-at-all-costs era has cooled. The broader reset in software valuations is the subject of our SaaS valuation reset analysis.

Rule of 40

A benchmark for software companies stating that revenue growth rate plus profit margin should sum to at least 40%. It captures the trade-off between growth and profitability, allowing an unprofitable company to still be considered healthy if its growth rate is high enough to offset its losses.

The limits of the rule

The Rule of 40 is a heuristic, not a valuation in itself. It says nothing about how durable the growth is, how good the unit economics are, or how the margin was achieved. A company can clear 40 by slashing investment in a way that mortgages its future. Treat it as a fast first screen, not a verdict.

Behind every revenue multiple and Rule of 40 score sits the question that actually determines whether an unprofitable company is a future profit machine or a cash incinerator: do the unit economics work? This is where serious valuation work happens.

Customer acquisition cost and lifetime value

The most important relationship is between how much it costs to acquire a customer (CAC) and how much that customer is worth over their lifetime (LTV). A healthy business generates an LTV several times its CAC, often cited as a target ratio of 3x or better. If a company spends $10,000 to win a customer who delivers $40,000 of lifetime gross profit, the model works even while the company reports losses, because it is investing in profitable customers faster than the income statement can show.

Gross margin and the payback period

Two related tests sharpen the picture. Gross margin reveals how much of each revenue dollar survives the direct cost of delivering the product, and software businesses are prized for margins of 70% to 80% or more. The CAC payback period, the number of months of gross profit needed to recoup acquisition cost, shows how quickly the investment is recovered. Short paybacks and high margins mean losses today are a choice, not a fate.

Net revenue retention

For subscription models, net revenue retention (NRR) measures how much revenue from existing customers grows or shrinks over a year, after churn and after upsells. An NRR above 100% means the existing customer base expands on its own, so the company would grow even if it never won a new customer. That is the single most powerful signal that a loss-making business has a real engine underneath the burn.

The final step is connecting today's revenue to tomorrow's earnings, because that conversion is what the whole valuation rests on.

The rule-of-thumb bridge

A quick way to sanity-check a revenue multiple is to translate it into the future earnings multiple it implies. Divide the revenue multiple by the company's expected mature profit margin to approximate a future EV/EBITDA.

A company at 8x revenue that can eventually run at a 25% EBITDA margin is implicitly trading at about 32x its future EBITDA. If that future multiple looks insane, the revenue multiple is too high; if it looks reasonable, the price may be justified. This forces an explicit assumption about the margin the business will reach at maturity.

The DCF approach for pre-profit companies

The most rigorous method is still a discounted cash flow built on the company's long-term economics. You project revenue growth fading over time, margins expanding toward a mature target as the business scales, and free cash flow eventually turning positive, then discount it all back at an appropriate WACC. The bulk of the value sits in the terminal value, because the cash flows in the early years are negative. That concentration of value in distant assumptions is exactly why DCFs for young companies are so sensitive, a fragility NYU Stern's Aswath Damodaran documents extensively in his valuation work and datasets.

Reverse-engineering the assumptions

Because forward assumptions drive everything, sophisticated analysts run the DCF backward. A reverse DCF starts from the current price and solves for the growth and margin the market must be assuming to justify it. If a price only works when you assume a company sustains 40% growth for a decade and reaches 30% margins, you can judge whether that is plausible. This reframes valuation from "what is it worth" to "what would have to be true", which is a far more honest question for a company with no profits.

Theory clicks when you run the numbers, so take a concrete case. A software company has $200 million of revenue growing 50% a year, a 75% gross margin, and an operating margin of negative 20%. How would you frame its value?

Step one: score the quality of growth

Its Rule of 40 score is 50% growth plus negative 20% margin, which equals 30. That sits below the 40 threshold, so the market would read the growth as solid but not elite, and the revenue multiple should land in a middle band rather than a premium one.

Step two: apply a revenue multiple

Suppose comparable high-growth software names trade around 8x forward revenue. At $200 million of revenue, that implies an enterprise value of roughly $1.6 billion. This is a starting hypothesis, not a conclusion, because the multiple itself still has to be justified.

Step three: sanity-check against future profit

Divide the 8x revenue multiple by a plausible mature EBITDA margin of 25%, and you get an implied forward EV/EBITDA of about 32x. Now the real question is sharp: should a business of this quality, several years out, trade at 32x mature earnings? If peers at maturity trade at 15x to 20x, the 8x revenue multiple is rich and the company must grow faster or reach higher margins to deserve it.

Revenue multiples assume there is meaningful revenue to multiply. Some companies, early-stage biotech, frontier-tech startups, and pre-launch platforms, have little or none, and they demand yet another toolkit.

Biotech and the probability-weighted pipeline

A clinical-stage biotech may have zero product revenue but a pipeline of drug candidates. Analysts value each candidate with a risk-adjusted net present value, projecting the cash flows if the drug reaches market and multiplying by the probability it survives each trial phase. The company's value becomes the sum of these probability-weighted assets, a sum-of-the-parts approach applied to science rather than business segments.

Risk-Adjusted NPV (rNPV)

A valuation method that projects the future cash flows of an asset, such as a drug candidate, and multiplies them by the probability the asset succeeds at each stage, then discounts the result to present value. It is the standard tool for valuing pre-revenue biotech pipelines, where most candidates fail.

The venture capital method

For startups, investors often work backward from an expected exit. The venture capital method estimates a future exit value, often a revenue multiple applied to projected revenue at exit, then discounts it back at a very high target return to reflect the risk of failure. It is crude, but it disciplines the conversation around what the company must achieve to justify today's round.

Comparable financings and recent rounds

When fundamentals are too immature to model, the price set in the most recent funding round, and in rounds for similar companies, often anchors the valuation. This is closer to pricing than to true valuation, but in the absence of revenue it is frequently the best signal available.

No discussion of valuing unprofitable companies is complete without the current extreme case: artificial intelligence.

Why AI multiples are off the charts

AI startups have raised at revenue multiples in the range of 25x to 30x or higher, against mid-single-digit multiples, roughly 3x to 6x, for the typical public SaaS company, a gap that has only widened as software multiples compressed through 2025 and 2026. Investors are paying for the possibility of enormous future scale and for the fear of missing the defining platform shift of the decade. Whether those multiples prove visionary or delusional is the open question explored in our piece on valuing AI companies like OpenAI and Anthropic.

The extra factors AI forces you to weigh

AI valuation adds wrinkles that classic SaaS analysis can ignore. Capital intensity is far higher, because training and serving models consumes enormous compute, so the cost of revenue includes heavy inference expense that pressures gross margin. Defensibility is murkier, since today's leading model can be leapfrogged in months. And the path to profitability depends on whether inference costs fall faster than prices, a genuinely uncertain race. These factors mean two AI companies with identical revenue can deserve wildly different multiples.

"How would you value a company with no earnings?" is a classic technical question, and a strong answer follows a clear logic rather than naming a single metric.

The structure of a good answer

Lead with the plain point that profit-based multiples do not work, then move to revenue or ARR multiples, immediately qualify them with growth and margins, and bring in the Rule of 40 as a quality screen. Then go deeper to unit economics, CAC, LTV, gross margin, and retention, to show you understand what actually drives future profit. Close with the DCF as the most rigorous method and note that the value lives in the terminal assumptions. That progression signals you can reason, not just recall. The same disciplined thinking underlies any private company valuation.

The judgment they are testing

The deeper thing interviewers want to see is whether you can hold the tension between optimism and skepticism. A loss-making company can be a generational investment or a value trap, and the difference lies in the durability of growth and the quality of unit economics. Show that you would dig into those, and that you treat a high multiple as a hypothesis to test rather than a verdict to accept, and you will stand out.

Get the complete framework set: Download our comprehensive 160-page PDF, access the IB Interview Guide covering valuation, DCF, and growth-company methods in depth.

A handful of errors recur often enough that simply avoiding them will set your analysis apart.

Quoting a multiple without context

The most frequent mistake is citing a revenue multiple with no growth rate or margin attached. As stressed throughout, the number is meaningless on its own, and an analyst who quotes "12x revenue" as if it settles anything reveals they have not done the work.

Assuming today's growth lasts forever

Every high growth rate fades as a company scales, and a valuation that extrapolates 50% growth indefinitely will be wildly too high. Mature companies eventually grow roughly with the economy, so the real skill is judging how quickly and how soon the deceleration arrives, since that fade drives most of the value in any model.

Ignoring stock-based compensation

Loss-making technology companies often pay employees heavily in equity, which flatters cash-based profitability while quietly diluting existing shareholders. Treating stock-based compensation as a free expense overstates value, and many "adjusted" profitability figures lean on exactly this sleight of hand. A rigorous valuation counts it as the real cost it is.

Confusing a cheap multiple with a cheap company

A company trading at a low multiple may be cheap for good reason: decelerating growth, weak retention, or broken unit economics. Equally, a high multiple is not automatically expensive. The multiple is the start of the analysis, not the verdict, and the work is explaining why it is what it is.

Valuing a company with no profits is less about a single formula and more about a disciplined argument: revenue stands in for future earnings, growth and unit economics determine whether that conversion is real, and the multiple is only as good as the assumptions behind it. Master that logic and you can value the most exciting and most dangerous companies in the market with the same rigor you would bring to a mature business, which is exactly the skill the modern market demands.